Virax Biolabs Group Limited Ordinary Shares
VRAXVirax Biolabs Group Limited is a biotechnology company that focuses on the development, manufacturing, and commercialization of vaccines and diagnostic products. The company aims to address infectious diseases through innovative health solutions, leveraging advanced technologies to improve global health outcomes.
Company News
Virax Biolabs Group Limited has entered into agreements for a private placement of 12,500,000 ordinary shares and preferred investment options at $0.40 per share, expecting to raise $5 million for working capital and corporate purposes.
Saudi Arabia made its debut at the BIO International Convention 2025, signing over a dozen partnerships, launching a national biotech accelerator program, and establishing the Kingdom as a global hub for life sciences. The Kingdom showcased its ecosystem ready for collaboration across scientific discovery, clinical research, and advanced therapeu...
Virax Biolabs has extended its exclusive distribution agreement with Cosmos Health to commercialize Mpox Virus Real-Time PCR Detection Kits in the Gulf Cooperation Council countries. The kits have high sensitivity and specificity and can deliver results in under 70 minutes.
Shares of LQR House Inc. (NASDAQ: LQR) rose sharply in pre-market trading. Borg's investor group has acquired a 20% stake in LQR House. LQR House shares jumped 16.1% to $4.25 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares rose 64% to $2.28 in pre-market trading after...
Shares of Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading. The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan. 31, 2024. Trinity Place shares jumped 80.1% to $0.2056 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Sig...
